| 000 | 01408 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250514213255.0 | ||
| 264 | 0 | _c20050705 | |
| 008 | 200507s 0 0 eng d | ||
| 022 | _a0041-1345 | ||
| 024 | 7 |
_a10.1016/j.transproceed.2004.09.060 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChang, H-R | |
| 245 | 0 | 0 |
_aSirolimus addition is beneficial for renal allograft dysfunction due to simultaneous acute rejection episode and calcineurin inhibitor nephrotoxicity. _h[electronic resource] |
| 260 |
_bTransplantation proceedings _cNov 2004 |
||
| 300 |
_a2668-70 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aCalcineurin Inhibitors |
| 650 | 0 | 4 |
_aCyclosporine _xtherapeutic use |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xsurgery |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xsurgery |
| 650 | 0 | 4 |
_aKidney Transplantation _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aReoperation |
| 650 | 0 | 4 |
_aSirolimus _xtherapeutic use |
| 650 | 0 | 4 |
_aTacrolimus _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLee, M-H | |
| 700 | 1 | _aWen, M-C | |
| 700 | 1 | _aLian, J-D | |
| 773 | 0 |
_tTransplantation proceedings _gvol. 36 _gno. 9 _gp. 2668-70 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.transproceed.2004.09.060 _zAvailable from publisher's website |
| 999 |
_c15302087 _d15302087 |
||